Moreover, the present in vitro findings contrasted these two VEGFR2 ligands in terms of the preferential gene upregulation of LGALS1 by IL-1β and VEGF165 by hypoxia in Müller glial cells (Supplementary Fig. S1), which are activated in various retinal diseases. The gene discussed is LGALS1; the disease is Abnormal retinal morphology.